Today

Agents

Chat

Arena

Discover

More

App

Climb Bio, Inc. <CLYM.O>: H.C. Wainwright raises target price to $24 from $20

CLYM•2026-08-24

Related News

IBM Unveils Next Generation Dual-Architecture Processor For IBM Z And Linuxone

IBM•2026-08-24

BJ's Wholesale Club Holdings, Inc. <BJ.N>: Deutsche Bank Raises Target Price to $103 From $94

BJ•2026-08-24

Monte Rosa doses first patient in Phase 2 MODeFIRe-1 trial of MRT-2359 plus apalutamide in mCRPC

GLUE•2026-08-24

AN2 Therapeutics names Cameron Trenor chief medical officer

ANTX•2026-08-24

FDA places clinical hold on Regenxbio RGX-121 gene therapy for Hunter syndrome after spine MRI findings

RGNX•2026-08-24

Climb Bio, Inc. <CLYM.O>: H.C. Wainwright raises target price to $24 from $20 - CLYM News | Rallies